Saba University School of Medicine
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Saba University School of Medicine - overview
Established
1986
Location
-, -, Netherlands
Primary Industry
Healthcare
About
Saba University School of Medicine specializes in offering an accredited Doctor of Medicine (MD) program, combining theoretical education with practical training, aimed at preparing students for careers as healthcare providers. Founded in 1986, Saba University School of Medicine is located in the Netherlands and offers medical education to international students. The institution has remained focused on providing quality medical training without significant shifts in its operational strategy. In April 2007, the university was acquired by Prairie Capital as part of a strategic development plan.
Saba University School of Medicine offers a comprehensive Doctor of Medicine (MD) program designed to train future physicians through a combination of classroom instruction and hands-on clinical training. The program spans four years, consisting of 10 semesters, starting with twenty months of foundational medical education on the island of Saba, followed by clinical rotations at affiliated teaching hospitals in the United States and Canada. The university holds global accreditation, recognized in all 50 U. S.
states, Canada, and the United Kingdom, serving a diverse client base of international medical students who seek quality education in a supportive environment. Additionally, Saba University has recently introduced pricing structures that allow Canadian students to pay tuition and administrative fees in CAD, catering specifically to the North American market. Saba University School of Medicine’s revenue structure is primarily derived from tuition fees collected from enrolled students in its MD program. This includes administrative fees and any additional costs associated with preparatory programs like the Gateway Medical Program, which helps students transition into the MD program.
Typically, students pay fees directly to the institution, creating a straightforward transaction model. Given the institution's focus on accessibility, new pricing plans for Canadian students reflect a strategic approach to expanding its customer base within that market. The university's established reputation in medical education and its strong residency placement rates contribute to the ongoing interest from prospective medical students, thereby influencing overall revenue generation. Saba University School of Medicine is focused on expanding its market presence, particularly through the introduction of new pricing structures aimed at Canadian students and further enhancing its MD program.
Recent funding from the acquisition in April 2007 is expected to support these initiatives, allowing for greater investment in marketing and outreach. The university aims to attract more international medical students by optimizing its educational offerings and potentially exploring new geographic regions for student recruitment, including additional outreach in North America.
Current Investors
R3 Education
Primary Industry
Healthcare
Sub Industries
Healthcare
Website
www.saba.edu
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Saba University School of Medicine - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Saba University School of Medicine | - |
Displaying 1 - 1 of 1
Saba University School of Medicine - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.